Document 0519
 DOCN  M9440519
 TI    Tuberculosis in developing countries.
 DT    9404
 AU    Porter JD; Department of Clinical Sciences, London School of Hygiene
       and; Tropical Medicine.
 SO    CDR (Lond Engl Rev). 1991 Nov 8;1(12):R136-9. Unique Identifier :
       AIDSLINE MED/94138431
 AB    Every year, between six and eight million people worldwide develop
       tuberculosis and 2-3 million die of the disease. The situation is
       worsening due to the epidemic of human immunodeficiency virus (HIV)
       infection and reactivation of tuberculosis in patients with 'dual
       infection'. The World Health Organisation estimated that three million
       persons had 'dual infection' in 1990; 78% occurring in Africa.
       Tuberculosis, which affects adults during their most productive years
       and is a curable and preventable disease, has thus become a priority in
       the 1990s after a period of neglect. It also has some of the most cost
       effective health interventions available. The thrust of tuberculosis
       research in developing countries should be to support national
       tuberculosis control programmes, both in the development of their
       infrastructure and in research, to assist and develop tuberculosis
       control strategies.
 DE    AIDS-Related Opportunistic Infections/*EPIDEMIOLOGY/PREVENTION &
       CONTROL  BCG Vaccine/ADMINISTRATION & DOSAGE  Communicable Disease
       Control  Comparative Study  Cross-Cultural Comparison  Cross-Sectional
       Studies  *Developing Countries  Human  Incidence  Mass Screening
       Tuberculosis/*EPIDEMIOLOGY/PREVENTION & CONTROL  Tuberculosis,
       Pulmonary/*EPIDEMIOLOGY/PREVENTION & CONTROL  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).